Skip to main content
. 2018 Dec 26;11(1):20. doi: 10.3390/cancers11010020
RT Radiotherapy
CRPC Castration-resistant prostate cancer
ADT Androgen deprivation therapy
MDSC Myeloid-derived suppressor cell
TIL Tumor-infiltrating T cells